<DOC>
	<DOCNO>NCT03071016</DOCNO>
	<brief_summary>This study non-interventional , multicentre , prospective , observational study conduct 50 site India . The study target enrol 2000 patient 40 patient per site . The study initiate obtain write approval Independent Ethics Committee ( IEC ) /Institutional Review Board ( IRB ) write informed consent patient .</brief_summary>
	<brief_title>Usage Dapagliflozin Management Type-2 Diabetes Mellitus : A Real World Evidence Study Indian Patients</brief_title>
	<detailed_description>This study non-interventional , multicentre , prospective , observational study conduct 50 site India . The study target enrol 2000 patient 40 patient per site . The study would enrol T2DM patient are/were inadequately control ( HbA1c &gt; 7 % ) exist anti-diabetic medication prescribe dapagliflozin 3 month prior study initiation . No study medication prescribe administered part study procedure . Patients , treat per Investigators ' routine clinical practice prescribe dapagliflozin 3 month screen enrolment study . Dosage dapagliflozin medication per routine clinical practice prescribe information . The study initiate obtain write approval Independent Ethics Committee ( IEC ) /Institutional Review Board ( IRB ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Male female patient 18 year . 2 . Patients provide write informed consent . 3 . Patients previously diagnose Type2 diabetes mellitus 4 . Patients inadequately control diabetes ( HbA1c &gt; 7 % ) exist antidiabetic medication , prior initiation dapagliflozin treatment . 5 . Patients take dapagliflozin within last 3 month . 1 . Patients Type1 diabetes mellitus 2 . Patients medical condition opinion investigator would interfere safe completion study 3 . Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>T2D ,</keyword>
	<keyword>Type 2 Diabetes ,</keyword>
	<keyword>T2DM</keyword>
</DOC>